• Involves oxidation, reduction, hydrolysis
• Primarily mediated by cytochrome P450 enzymes (CYP450)
• Can activate, inactivate, or generate toxic metabolites
• ↓ in elderly and liver disease, increasing risk of toxicity
• Involves conjugation reactions (e.g. glucuronidation, sulfation, acetylation)
• Converts drugs into more water-soluble compounds for renal or biliary excretion
• Generally preserves drug activity or enhances clearance
• Alcohol (chronic)
• Phenytoin
• Griseofulvin
• Phenobarbital
• St John's Wort
• Sodium valproate
• Cimetidine
• Ketoconazole
• Fluconazole
• Alcohol (acute)
• Chloramphenicol
• Erythromycin
• Sulfonamides
• Ciprofloxacin
• Omeprazole
• Metronidazole
Pharmacokinetic Concepts
• Drugs absorbed via the GI tract pass through the liver via portal circulation before entering systemic
circulation
• Significant hepatic metabolism reduces bioavailability
• Examples: propranolol, verapamil, GTN, morphine
• Narrow therapeutic index = small gap between effective and toxic doses
• Requires regular monitoring
• Examples: digoxin, lithium, warfarin, theophylline, phenytoin
Clinical Implications
• ↑ Risk of toxicity: e.g. erythromycin (inhibitor) + warfarin → ↑ INR → bleeding
• ↓ Efficacy: e.g. enzyme inducers reduce levels of immunosuppressants, anti-epileptics
• Due to:
o Enzyme inducers (e.g. rifampicin, carbamazepine)
o Malabsorption (e.g. vomiting, diarrhoea)
• Warfarin + antibiotics (e.g. erythromycin, metronidazole) → ↑ INR
• Theophylline + ciprofloxacin → toxicity
• Statins + macrolides (e.g. clarithromycin) → rhabdomyolysis
• SSRIs + tramadol → serotonin syndrome
————————————————————————————————————————————————————————————————————————————————————————————————————————-
Author & Educational Disclaimer
Author:
Dr Phillip Cockrell BM FRCP DipClinEd
Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.
He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.
Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.
Purpose of this content:
The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.
Medical disclaimer:
This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.